Evidence map›Paper›PMID 40631077›Full record

ArticlebioRxiv : the preprint server for biology2025

PROFET Predicts Continuous Gene Expression Dynamics from scRNA-seq Data to Elucidate Heterogeneity of Cancer Treatment Responses.

Yu-Chen Cheng, Hyemin Gu, Thomas O McDonald, Wenbo Wu, Shubham Tripathi, Cristina Guarducci, Douglas Russo, Daniel L Abravanel, Madeline Bailey, Yue Wang and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Yu-Chen ChengDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Hyemin GuDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, MA, USA.
Thomas O McDonaldDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Wenbo WuHarvard-MIT Health Sciences and Technology, Cambridge, MA, USA.
Shubham TripathiYale Center for Systems and Engineering Immunology and Department of Immunobiology , Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0141-987X
Cristina GuarducciDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Douglas RussoDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Daniel L AbravanelDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Madeline BaileyDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Yue WangIrving Institute for Cancer Dynamics and Department of Statistics, Columbia University, New York, NY, USA.ORCID 0000-0001-5918-7525
Yun ZhangState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yannis PantazisInstitute of Applied and Computational Mathematics, Foundation for Research and Technology-Hellas, Greece.
Herbert LevineCenter for Theoretical Biological Physics, Northeastern University, Boston, MA, USA.
Rinath JeselsohnDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Markos A KatsoulakisDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, MA, USA.
Franziska MichorDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI LEIF W ELLISEN, NANCY U LIN · 2013 to 2026
$30.1M
NCI NIH HHS P50 CA168504
6 · The paper itself

Abstract

Single-cell RNA sequencing captures static snapshots of gene expression but lacks the ability to track continuous gene expression dynamics over time. To overcome this limitation, we developed PROFET (Particle-based Reconstruction Of generative Force-matched Expression Trajectories), a computational framework that reconstructs continuous, nonlinear single-cell gene expression trajectories from sparsely sampled scRNA-seq data. PROFET first generates particle flows between time-stamped samples using a novel Lipschitz-regularized gradient flow approach and then learns a global vector field for trajectory reconstruction using neural force-matching. The framework was developed using synthetic data simulating cell state transitions and subsequently validated on both mouse and human

Identifiers

PMID40631077
PMCPMC12236938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.